Meeting
2022 ASCO Annual Meeting
Identifying biomarkers associated with disease-free survival in stage I non–small cell lung cancer.
Authors
Christopher W. Seder
Rush University Medical Center, Chicago, IL
Christopher W. Seder , Hita Moudgalya , Andrew E. Donaldson , Kayla Viets Layng , Elizabeth Mauer , Janakiraman Subramanian , Cristina L. Fhied , Nicole Geissen , Gillian Alex , Justin Karush , Michael J. Liptay , Jeffrey Allen Borgia
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers
Track
Lung Cancer
Sub Track
Local-Regional Non–Small Cell Lung Cancer
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 8543)
DOI
10.1200/JCO.2022.40.16_suppl.8543
Abstract #
8543
Poster Bd #
170
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
A master screening study to determine biomarker status and trial eligibility for patients with malignant tumors.
First Author: Benjamin J. Solomon
Poster
2022 ASCO Annual Meeting
Molecular characterization of NF1-mutated NSCLC and clinical outcomes.
First Author: Christopher Gates
Poster
2019 ASCO Annual Meeting
Mutational landscapes and PD-L1 expression in non-small cell lung cancer.
First Author: Kang Zhang
Poster
2018 ASCO Annual Meeting
Association of CDKN2A gene alteration with high expression of PD-L1.
First Author: Yan Zhang